Cargando…
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857121/ https://www.ncbi.nlm.nih.gov/pubmed/33545166 http://dx.doi.org/10.1016/j.jinf.2021.01.023 |
_version_ | 1783646384179642368 |
---|---|
author | Borgonovo, Fabio Passerini, Matteo Piscaglia, Marco Morena, Valentina Giacomelli, Andrea Oreni, Letizia Dedivitiis, Gianfranco Lupo, Angelica Falvella, Stefania Cossu, Maria Vittoria Capetti, Amedeo F. |
author_facet | Borgonovo, Fabio Passerini, Matteo Piscaglia, Marco Morena, Valentina Giacomelli, Andrea Oreni, Letizia Dedivitiis, Gianfranco Lupo, Angelica Falvella, Stefania Cossu, Maria Vittoria Capetti, Amedeo F. |
author_sort | Borgonovo, Fabio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7857121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The British Infection Association. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78571212021-02-04 Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study Borgonovo, Fabio Passerini, Matteo Piscaglia, Marco Morena, Valentina Giacomelli, Andrea Oreni, Letizia Dedivitiis, Gianfranco Lupo, Angelica Falvella, Stefania Cossu, Maria Vittoria Capetti, Amedeo F. J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-05 2021-02-03 /pmc/articles/PMC7857121/ /pubmed/33545166 http://dx.doi.org/10.1016/j.jinf.2021.01.023 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Borgonovo, Fabio Passerini, Matteo Piscaglia, Marco Morena, Valentina Giacomelli, Andrea Oreni, Letizia Dedivitiis, Gianfranco Lupo, Angelica Falvella, Stefania Cossu, Maria Vittoria Capetti, Amedeo F. Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
title | Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
title_full | Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
title_fullStr | Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
title_full_unstemmed | Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
title_short | Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study |
title_sort | is covid-19 severity associated with anti-spike antibody duration? data from the arcovid prospective observational study |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857121/ https://www.ncbi.nlm.nih.gov/pubmed/33545166 http://dx.doi.org/10.1016/j.jinf.2021.01.023 |
work_keys_str_mv | AT borgonovofabio iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT passerinimatteo iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT piscagliamarco iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT morenavalentina iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT giacomelliandrea iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT oreniletizia iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT dedivitiisgianfranco iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT lupoangelica iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT falvellastefania iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT cossumariavittoria iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy AT capettiamedeof iscovid19severityassociatedwithantispikeantibodydurationdatafromthearcovidprospectiveobservationalstudy |